Literature DB >> 3146770

Comparison of alprazolam plasma levels in normal Asian and Caucasian male volunteers.

K M Lin1, J K Lau, R Smith, P Phillips, E Antal, R E Poland.   

Abstract

Single-dose pharmacokinetics of alprazolam was studied in 42 normal male volunteers (14 Caucasians, 14 American-born Asians, and 14 foreign-born Asians), after both oral and parenteral (IV) administration of a small dose (0.5 mg) of the test drug. Asians manifested significantly higher Cmax, larger AUC, slower CL and longer t1/2 under both testing situations. When body surface area was used as a covariate, these cross-ethnic differences remained statistically significant (except Cmax) after oral but not IV drug administration. There were no differences between the two Asian groups in any of these parameters examined in this study. These results confirmed previous observations of ethnic differences in the pharmacokinetic response between Asians and Caucasians and suggested that smaller doses of alprazolam may be required for Asians for similar clinical effects as compared to their Caucasian counterparts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146770     DOI: 10.1007/bf00216063

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Prophylactic efficacy of lithium and its effective plasma levels in Chinese bipolar patients.

Authors:  Y Y Yang
Journal:  Acta Psychiatr Scand       Date:  1985-02       Impact factor: 6.392

2.  Racial mydriatic response to belladonna premedication.

Authors:  J F Garde; R Aston; G C Endler; O S Sison
Journal:  Anesth Analg       Date:  1978 Sep-Oct       Impact factor: 5.108

3.  Ethnicity and psychopharmacology.

Authors:  K M Lin; R E Poland; I M Lesser
Journal:  Cult Med Psychiatry       Date:  1986-06

4.  Nortriptyline kinetics in Japanese and Americans.

Authors:  A Kishimoto; L E Hollister
Journal:  J Clin Psychopharmacol       Date:  1984-06       Impact factor: 3.153

Review 5.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

6.  Antipyrene clearance in Indian villagers.

Authors:  N K Desai; U K Sheth; J C Mucklow; H S Fraser; C J Bulpitt; S W Jones; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

7.  Environmental factors affecting antipyrine metabolism in London factory and office workers.

Authors:  H S Fraser; J C Mucklow; C J Bulpitt; C Kahn; G Mould; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

8.  Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration.

Authors:  R B Smith; P D Kroboth; J T Vanderlugt; J P Phillips; R P Juhl
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Haloperidol concentrations elevated in Chinese patients.

Authors:  S G Potkin; Y Shen; H Pardes; B H Phelps; D Zhou; L Shu; E Korpi; R J Wyatt
Journal:  Psychiatry Res       Date:  1984-06       Impact factor: 3.222

10.  Diphenhydramine in Orientals and Caucasians.

Authors:  R Spector; A K Choudhury; C K Chiang; M J Goldberg; M M Ghoneim
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

View more
  15 in total

Review 1.  Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.

Authors:  Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

3.  Cross-cultural issues and psychopharmacology in asian-americans.

Authors:  J Yamamoto
Journal:  West J Med       Date:  1989-09

4.  Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.

Authors:  Guo Yu; Hong-Hao Zhou; Qing-Shan Zheng; Guo-Fu Li
Journal:  Eur J Clin Pharmacol       Date:  2018-12-19       Impact factor: 2.953

Review 5.  Clinical trials and transethnic pharmacology.

Authors:  M E Kitler
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

6.  Pharmacokinetics of Roflumilast and Its Active Metabolite Roflumilast N-Oxide in Healthy Chinese Subjects After Single and Multiple Oral Doses.

Authors:  Qian Li; Yiya Wang; Lingye Liu; Pengcheng Ma; Li Ding
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

7.  The pharmacokinetics and pharmacodynamics of adinazolam: multi-ethnic comparisons.

Authors:  K Ajir; M Smith; K M Lin; J C Fleishaker; J H Chambers; D Anderson; I Nuccio; Y Zheng; R E Poland
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

Review 8.  Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

Authors:  L L von Moltke; D J Greenblatt; J Schmider; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

9.  Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling.

Authors:  Zoe E Barter; Geoffrey T Tucker; Karen Rowland-Yeo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics of alprazolam. Therapeutic implications.

Authors:  D J Greenblatt; C E Wright
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.